Aemetis (NASDAQ:AMTX) Stock Crosses Below Two Hundred Day Moving Average – Time to Sell?

Shares of Aemetis, Inc (NASDAQ:AMTX) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.03 and traded as low as $1.61. Aemetis shares last traded at $1.6950, with a volume of 8,316,770 shares.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Ascendiant Capital Markets raised their price objective on Aemetis from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Friday, May 22nd. Weiss Ratings reissued a “sell (e+)” rating on shares of Aemetis in a report on Monday, April 20th. Loop Capital set a $1.75 price objective on shares of Aemetis in a report on Thursday, March 12th. Finally, Wall Street Zen downgraded shares of Aemetis from a “hold” rating to a “sell” rating in a report on Saturday, June 6th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Aemetis presently has an average rating of “Hold” and a consensus target price of $8.92.

Aemetis Price Performance

The stock has a fifty day moving average of $2.38 and a 200 day moving average of $2.03. The stock has a market cap of $119.28 million, a price-to-earnings ratio of -1.42 and a beta of 1.36.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Thursday, May 7th. The specialty chemicals company reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.06). The firm had revenue of $54.62 million during the quarter, compared to analyst estimates of $66.70 million. As a group, equities analysts expect that Aemetis, Inc will post -1.11 earnings per share for the current fiscal year.

Institutional Trading of Aemetis

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Royal Bank of Canada raised its holdings in shares of Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock valued at $28,000 after acquiring an additional 8,825 shares during the last quarter. Sanctuary Advisors LLC purchased a new position in shares of Aemetis in the first quarter worth about $33,000. Creative Planning purchased a new position in shares of Aemetis in the second quarter worth about $30,000. Prairiewood Capital LLC acquired a new position in Aemetis during the first quarter worth about $47,000. Finally, Engineers Gate Manager LP purchased a new stake in Aemetis during the 2nd quarter valued at about $42,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

About Aemetis

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.